← Back to the feed

MUVON Therapeutics AG

History from 29 Oct 2020

UID

CHE-218.760.672

Legal form

AG

Canton

ZH

Founded

29 Oct 2020

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 3 Nov 2020 · legal date 29 Oct 2020

   Company formed

   Founded 29 Oct 2020

   SHAB HR01-1005013323 ↗

2. SHAB published 11 Oct 2023 · legal date 26 Sep 2023

   Capital band adopted

   SHAB HR02-1005857567 ↗

3. SHAB published 9 Jul 2024 · legal date 3 Jul 2024

   Capital increase

   Not assessed

   Paid in cash and by other means

   Nominal capital

   100’000 → 105’312.10

   Shares

   1’000’000 → 1’053’121

   New shares, % of post-step shares

   5.0% (53’121 new)

   Aktienkapital neu: CHF 105'312.10 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 105'312.10 [bisher: CHF 100'000.00]. Aktien neu: 1'053'121 Namenaktien zu CHF 0.10 [bisher: 1'000'000 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

   SHAB HR02-1006079120 ↗

4. SHAB published 13 Aug 2026 · legal date 6 Aug 2026

   Capital increase

   ●●○Likely financing

   Paid in cash and by other means

   Nominal capital

   105’312.10 → 112’306.20

   Shares

   1’053’121 → 1’123’062

   New shares, % of post-step shares

   6.2% (69’941 new)

   Aktienkapital neu: CHF 112'306.20 [bisher: CHF 105'312.10]. Liberierung Aktienkapital neu: CHF 112'306.20 [bisher: CHF 105'312.10]. Aktien neu: 1'123'062 Namenaktien zu CHF 0.10 [bisher: 1'053'121 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.70 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006730160 ↗

Published by 16 Aug 2026

Latest available record · 8 Oct 2026